{"id":"W2921283293","doi":"10.14309/00000434-201810001-00659","title":"Vedolizumab Outcomes in Real-world Bio-naive Ulcerative Colitis and Crohnʼs Disease Patients (EVOLVE) in North America","year":2018,"lang":"en","type":"article","venue":"The American Journal of Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"Takeda (Canada)","funders":"","keywords":"Vedolizumab; Medicine; Ulcerative colitis; Discontinuation; Internal medicine; Gastroenterology; Crohn's disease; Infliximab; Cohort; Retrospective cohort study; Surgery; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0006841382,0.0001886026,0.0003606535,0.0005306959,0.0003642015,0.0007191059,0.000214516,0.0003721781,0.0009531475],"category_scores_gemma":[0.001159595,0.0001830675,0.0003504979,0.001045689,0.0003006978,0.0004075226,0.0005173516,0.0003032188,0.0001430437],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005631713,"about_ca_system_score_gemma":0.0003991924,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.006067743,"about_ca_topic_score_gemma":0.006846488,"domain_scores_codex":[0.999525,0.0001489687,0.00005560594,0.0001363182,0.00006405114,0.00007002025],"domain_scores_gemma":[0.9987374,0.000164191,0.0007563402,0.00005361959,0.00008642196,0.0002019605],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.0004701323,0.00004780327,0.9976712,0.00002156687,0.00008242761,0.00009042324,0.0001070536,0.00003916157,0.0001050401,0.00001231378,0.00010729,0.001245668],"study_design_scores_gemma":[0.00004198645,0.0002308127,0.9987863,0.00001167596,0.00004866367,0.0002776076,0.0002389371,0.00009713182,0.00002330712,0.0000116298,0.0002290255,0.000002912814],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.999159,0.0003229168,0.00001745968,0.00003193613,0.000002492059,0.000007159379,0.0002795113,0.000001077715,0.0001784965],"genre_scores_gemma":[0.9991819,0.0001517858,0.00002427676,0.0000298669,0.000009496232,0.000009988401,0.0005388729,6.670696e-7,0.00005304054],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.006067743,"threshold_uncertainty_score":0.01206487,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00573260333046231,"score_gpt":0.2452853885182373,"score_spread":0.239552785187775,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}